Uncategorized
Opinion: Don’t believe headlines saying that vaccine skepticism is widespread
Two years ago, I wrote in the New England Journal of Medicine that one of the greatest threats to childhood vaccination is the normalization of skepticism, even though it isn’t actually the norm. When credible outlets, trusted voices, and social media algorithms tell the public that most Americans doubt vaccines, some may start to wonder if they should, too. I watched that play out this week.
On Monday, Politico published a poll on vaccine attitudes titled, “More Americans doubt vaccine safety than trust it, Politico Poll finds,” followed by the subhead, “Health Secretary Robert F. Kennedy Jr.’s views are commonplace across the land.” I consider Politico a reputable news outlet, so this headline stopped me in my tracks.
Two years ago, I wrote in the New England Journal of Medicine that one of the greatest threats to childhood vaccination is the normalization of skepticism, even though it isn’t actually the norm. When credible outlets, trusted voices, and social media algorithms tell the public that most Americans doubt vaccines, some may start to wonder if they should, too. I watched that play out this week.
On Monday, Politico published a poll on vaccine attitudes titled, “More Americans doubt vaccine safety than trust it, Politico Poll finds,” followed by the subhead, “Health Secretary Robert F. Kennedy Jr.’s views are commonplace across the land.” I consider Politico a reputable news outlet, so this headline stopped me in my tracks.
As technology becomes more integrated and personalized, experts say the biggest opportunity in diabetes management is reducing everyday burdens.
With an IPO raise of $625 million, Kailera Therapeutics now holds the new record for the largest public market debut.
Uncategorized
Denali CEO’s ‘greatest professional moment’ arrives as rare disease drug launches
Denali CEO’s ‘greatest professional moment’ arrives as rare disease drug launches
After receiving the FDA’s greenlight for Hunter syndrome drug Avlayah, Denali Therapeutics CEO Ryan Watts saw the culmination of 20 years of hard work unraveling the mysteries of the blood-brain barrier. Read More
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
The 5 largest IPOs in biopharma history
The next phase of diabetes care
Denali CEO’s ‘greatest professional moment’ arrives as rare disease drug launches
Why key opinion leader enthusiasm often doesn’t predict future commercial success
#AAN26: Roche’s multiple sclerosis pill delays relapse, but liver toxicity could need monitoring
STAT+: With successful trials, Roche takes its MS drug to regulators, but safety questions loom
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Contributors9 years ago
The final 6 ‘Game of Thrones’ episodes might feel like a full season
-
Uncategorized9 years ago
According to Dior Couture, this taboo fashion accessory is back
-
Uncategorized9 years ago
Phillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years ago
Uber and Lyft are finally available in all of New York State
-
Uncategorized9 years ago
The old and New Edition cast comes together to perform
-
Uncategorized9 years ago
Steph Curry finally got the contract he deserves from the Warriors
-
Uncategorized9 years ago
Disney’s live-action Aladdin finally finds its stars